Additional Details
-
Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
University of RochesterRochester NY. 14642 -
Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
University of LouisvilleLouisville KY. 40202 -
Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Beaumont Hospital, Royal OakRoyal Oak MI. 48073 -
Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Indiana University HealthIndianapolis IN. 46202 -
Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Baylor University Medical CenterDallas TX. 75246 -
Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Icahn School of Medicine at Mount SinaiNew York NY. 10029 -
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Washington University School of MedicineSaint Louis MO. 63110 -
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Pennsylvania State Hershey Medical Center and College of MedicineHershey PA. 17033 -
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
St.Paul's HospitalVancouver BC. V6Z 176 -
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Northwestern Memorial Hospital, Clinical Research UnitChicago IL. 60611 -
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Weill Cornell Medicine, New York-Presbyterian HospitalNew York NY. 10065 -
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
The Emory ClinicAtlanta GA. 45227 -
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Houston Methodist Outpatient CenterHouston TX. 77030 -
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Hôpital Maisonneuve-RosemontMontreal QC. H1T 2M4 -
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
University of Cincinnati Medical CenterCincinnati OH. 45219 -
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Peter Morton Medical BuildingLos Angeles CA. 90095 -
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Saint Luke's Hospital of Kansas CityKansas City MO. 64111 -
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
St.Joseph's Healthcare HamiltonHamilton ON. L8N 4A6 -
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Mercy Health St.Vincent Medical Center LLCToledo OH. 43608